Overview
- Editors:
-
-
Werner J. Schmidt
-
Department of Neuropharmacology Zoological Institute, University of Tübingen, Tübingen, Germany
-
Maarten E. A. Reith
-
Department of Psychiatry, New York University School of Medicine, New York
Access this book
Other ways to access
Table of contents (24 chapters)
-
Attention Deficit Hyperactivity Disorder
-
- James M. Swanson, Nora D. Volkow, Jeffrey Newcorn, B. J. Casey, Robert Moyzis, David K. Grandy et al.
Pages 293-315
-
Addiction
-
Front Matter
Pages 317-317
-
- Richard J. Beninger, Todor V. Gerdjikov
Pages 319-354
-
- David A. Baker, Peter W. Kalivas
Pages 355-369
-
-
- Anton Y. Bespalov, Robert L. Balster
Pages 387-412
-
Neurodegeneration
-
Front Matter
Pages 413-413
-
- Gabriele Gille, Peter Riederer
Pages 415-445
-
- Antonello Novelli, Marcos Pérez-Basterrechea, Maria Teresa Fernández-Sánchez
Pages 447-472
-
Parkinson’s Disease
-
Front Matter
Pages 473-473
-
- Heiko Braak, Kelly Del Tredici
Pages 475-502
-
- Heinz Reichmann, Bernd Janetzky, Peter Riederer
Pages 503-522
-
-
Huntington’s Disease
-
Front Matter
Pages 537-537
-
- Carlos Cepeda, Marjorie A. Ariano, Michael S. Levine
Pages 539-565
-
Dementias
-
Front Matter
Pages 567-567
-
-
Back Matter
Pages 583-600
About this book
An illuminating summary of our current understanding of the interactive role of dopamine and glutamate in psychiatric diseases and the therapeutic strategies and possibilities for future treatment. Among the new ideas presented are hypotheses on the role of dopamine and glutamate in aggression, the glutamate system in anxiety disorders, glutamate and neurodegeneration, and on the origin and progression of Parkinson's disease. Additional chapters offer novel insights into a variety of psychiatric diseases, including ADHD, stress, aggression, addiction, schizophrenia, depression, social phobias, dementias, bulimia, and neurodegenerative diseases like Parkinson's and Alzheimer's diseases. Each chapter summarizes the prevalence and symptoms of the disease and explains the involvement of dopamine and/or glutamate systems using the newer molecular approaches such as transgenic knockout or knockin mice and recent brain imaging techniques.
Reviews
"...offers an excellent review of our understanding of how dopamine and glutamate influence the pathophysiology of psychiatric disease...an impressive effort, and every psychiatrist (and neurologist) should have this book in their reference library." - 4 Stars, Doody's Health Sciences and Book Review Journal
Editors and Affiliations
-
Department of Neuropharmacology Zoological Institute, University of Tübingen, Tübingen, Germany
Werner J. Schmidt
-
Department of Psychiatry, New York University School of Medicine, New York
Maarten E. A. Reith